Search research articles
Contact Us
Filters
Showing results (1-10 of 46) with videos related to
Page
of 5
Sort By:
F1000 Medicine Reports
|
February 2, 2011
Proteomics in rheumatology: the dawn of a new era
Kamala Vanarsa, Chandra Mohan
Expert Review of Proteomics
|
January 11, 2021
Targeted urine proteomics in lupus nephritis - a meta-analysis
Ting Zhang, Valeria Duran, Kamala Vanarsa, et al.
Arthritis Research & Therapy
|
August 9, 2012
Inflammation associated anemia and ferritin as disease markers in SLE
Kamala Vanarsa, Yujin Ye, Jie Han, et al.
Frontiers in Immunology
|
September 12, 2022
Exploring urine:serum fractional excretion ratios as potential biomarkers for lupus nephritis
Samar A Soliman, Samantha Stanley, Kamala Vanarsa, et al.
Rheumatology (Oxford, England)
|
August 12, 2022
Urinary CD163 is a marker of active kidney disease in childhood-onset lupus nephritis
Haleigh Inthavong, Kamala Vanarsa, Jessica Castillo, et al.
Clinical Immunology (Orlando, Fla.)
|
April 19, 2025
1000-plex antibody array proteomic screen uncovers PGRPS, Haptoglobin, Serpin A4 and Fibrinogen as potential stool biomarkers of pediatric inflammatory bowel disease
Ryan Pereira, Sanam Soomro, Kamala Vanarsa, et al.
Nutrients
|
August 1, 2019
Low dose Epigallocatechin Gallate Alleviates Experimental Colitis by Subduing Inflammatory Cells and Cytokines, and Improving Intestinal Permeability
Yong Du, Huihua Ding, Kamala Vanarsa, et al.
Plos One
|
August 23, 2016
Leukocyte Beta-Catenin Expression Is Disturbed in Systemic Lupus Erythematosus
Jacob J Orme, Yong Du, Kamala Vanarsa, et al.
BMC Medicine
|
April 4, 2023
Comprehensive proteomics and platform validation of urinary biomarkers for bladder cancer diagnosis and staging
Kamala Vanarsa, Jessica Castillo, Long Wang, et al.
Nutrients
|
March 6, 2021
Epigallocatechin-3-Gallate Dampens Non-Alcoholic Fatty Liver by Modulating Liver Function, Lipid Profile and Macrophage Polarization
Yong Du, Laura Paglicawan, Sanam Soomro, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 46) with videos related to
Sort By:
Page
of 5
F1000 Medicine Reports
|
February 2, 2011
Proteomics in rheumatology: the dawn of a new era
Kamala Vanarsa, Chandra Mohan
Expert Review of Proteomics
|
January 11, 2021
Targeted urine proteomics in lupus nephritis - a meta-analysis
Ting Zhang, Valeria Duran, Kamala Vanarsa, et al.
Arthritis Research & Therapy
|
August 9, 2012
Inflammation associated anemia and ferritin as disease markers in SLE
Kamala Vanarsa, Yujin Ye, Jie Han, et al.
Frontiers in Immunology
|
September 12, 2022
Exploring urine:serum fractional excretion ratios as potential biomarkers for lupus nephritis
Samar A Soliman, Samantha Stanley, Kamala Vanarsa, et al.
Rheumatology (Oxford, England)
|
August 12, 2022
Urinary CD163 is a marker of active kidney disease in childhood-onset lupus nephritis
Haleigh Inthavong, Kamala Vanarsa, Jessica Castillo, et al.
Clinical Immunology (Orlando, Fla.)
|
April 19, 2025
1000-plex antibody array proteomic screen uncovers PGRPS, Haptoglobin, Serpin A4 and Fibrinogen as potential stool biomarkers of pediatric inflammatory bowel disease
Ryan Pereira, Sanam Soomro, Kamala Vanarsa, et al.
Nutrients
|
August 1, 2019
Low dose Epigallocatechin Gallate Alleviates Experimental Colitis by Subduing Inflammatory Cells and Cytokines, and Improving Intestinal Permeability
Yong Du, Huihua Ding, Kamala Vanarsa, et al.
Plos One
|
August 23, 2016
Leukocyte Beta-Catenin Expression Is Disturbed in Systemic Lupus Erythematosus
Jacob J Orme, Yong Du, Kamala Vanarsa, et al.
BMC Medicine
|
April 4, 2023
Comprehensive proteomics and platform validation of urinary biomarkers for bladder cancer diagnosis and staging
Kamala Vanarsa, Jessica Castillo, Long Wang, et al.
Nutrients
|
March 6, 2021
Epigallocatechin-3-Gallate Dampens Non-Alcoholic Fatty Liver by Modulating Liver Function, Lipid Profile and Macrophage Polarization
Yong Du, Laura Paglicawan, Sanam Soomro, et al.
Page
of 5